A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)
Clinical trial NCT02451514 · COMPLETED
Trial details
- NCT number
- NCT02451514
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-30
- Primary completion
- 2015-11-14
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.